期刊文献+

血清apo A1、apo B、apo E与特应性皮炎的相关性 被引量:6

Correlation between serum apo A1,apo B,apo E and atopic dermatitis
下载PDF
导出
摘要 目的探讨血清载脂蛋白(apo)A1、apo B、apo E水平与特应性皮炎(AD)的相关性。方法选取230例AD患者及100名无过敏性疾病史的体检健康者,检测血清apo A1、apo B、apo E、总免疫球蛋白E(IgE)及过敏原[特异性免疫球蛋白E(sIgE)]水平。采用Logistic回归分析评估各项目及其与AD发病风险的关系。结果AD组和正常对照组女性血清apo A1水平均高于男性(P<0.05)。AD组女性血清apo A1水平高于正常对照组女性(P<0.05)。AD组男性血清apo B水平低于正常对照组男性(P<0.01)。sIgE阳性者男女比例与总IgE>200 kU/L者比较,差异无统计学意义(P>0.05)。以7岁为年龄分组界限,≤7岁组与>7岁组sIgE阳性率和总IgE>200 kU/L比例差异均无统计学意义(P>0.05)。apo A1、apo B与apo E均呈正相关(r值分别为0.190、0.287,P<0.01)。apo A1与apo B无相关性(r=0.030,P>0.05)。apo A1、apo B和apo E均与年龄呈正相关(r值分别为0.191、0.417、0.143,P<0.01)。Logistic回归分析结果显示,apo A1可增加AD的发病风险[比值比(OR)=7.346,95%可信区间(CI)为2.349~22.977],但与总IgE和sIgE无关;apo B校正年龄、性别后与AD发病风险无关,但可增加总IgE>200 kU/L的风险(OR=6.694,95%CI为1.739~25.762)。apo E无论是否校正年龄和性别均与AD发病风险、总IgE和sIgE无关。结论apo A1可能是独立于IgE介导的参与AD发病的危险因子。apo B受年龄、性别等因素的影响较大,与AD发病风险的关系尚不明确。apo E与AD的发病风险无关。 Objective To investigate the relationship between atopic dermatitis and the levels of serum apolipoprotein(apo)A1,apo B and apo E.Methods Totally,230 AD patients and 100 healthy subjects without the history of allergic diseases were enrolled.The levels of apo A1,apo B,apo E,total immunoglobulin E(IgE)and allergen[specific immunoglobulin E(sIgE)]were determined.Logistic regression analysis was used to evaluate the relationship between all the items and AD risk.Results Serum apo A1 levels of females in AD group and healthy control group were higher than those of males(P<0.05).Serum apo A1 level of females in AD group was higher than that in healthy control group(P<0.05).Serum apo B level of males in AD group was lower than that in healthy control group(P<0.01).There was no statistical significance for the ratio of males and females with positive sIgE and total IgE>200 kU/L(P>0.05),and there was no statistical significance between the group≤7 years old and the group>7 years old(P>0.05).Serum apo A1,apo B and apo E were positively correlated(r=0.190 and 0.287,respectively,P<0.01).Serum apo A1 and apo B were not correlated(r=0.030,P>0.05).Serum apo A1,apo B and apo E were positively correlated with age(r=0.191,0.417 and 0.143,respectively,P<0.01).Logistic regression analysis showed that apo A1 could enable AD happening easily[odds ratio(OR)=7.346,95%confidence interval(CI)2.349-22.977],however,total IgE and sIgE had no correlation.After adjusting age and sex,apo B was not correlated with the risk of AD,while it can put total IgE>200 kU/L more in danger(OR=6.694,95%CI 1.739-25.762).Serum apo E always had no correlation with the risk of AD,total IgE and sIgE regardless of age or sex adjustment.Conclusions Serum apo A1 may be a risk factor contributing to the risk of AD,which is independent from IgE mediating.As apo B is influenced by factors,like age and sex,whether it can contribute to the risk of AD is not clear.Serum apo E will not cause the risk of AD.
作者 唐满玲 周娟 蒋最明 顾敏 林伟 李见红 胡卫 李娟 罗文辉 TANG Manling;ZHOU Juan;JIANG Zuiming;GU Min;LIN Wei;LI Jianhong;HU Wei;LI Juan;LUO Wenhui(Department of Clinical Laboratory,Zhuzhou Central Hospital,Central South University Xiangya School of Medicine,Zhuzhou 412007,Hunan,China)
出处 《检验医学》 CAS 2020年第1期11-14,共4页 Laboratory Medicine
基金 株洲市指导性科研计划项目
关键词 载脂蛋白A1 载脂蛋白B 载脂蛋白E 免疫球蛋白E 特应性皮炎 Apolipoprotein A1 Apolipoprotein B Apolipoprotein E Immunoglobulin E Atopic dermatitis
  • 相关文献

参考文献4

二级参考文献37

  • 1杨昌国,李清华,许叶.载脂蛋白AI和B的免疫浊度自动分析法[J].临床检验杂志,1995,13(6):287-290. 被引量:9
  • 2王抒,李健斋,赵淑华,唐蔚青,褚德发,李培瑛,满咏,李红霞.血清载脂蛋白参考值[J].中华医学检验杂志,1996,19(6):343-348. 被引量:30
  • 3Jungner I, Marcovina SM, Walldius G, Holme I, Kolar W, Steiner E. Apolipoprotein B and A1 values in 147 576 Swedish males and females, standardized according to the World Health Organization-International Federation of Clinical Chemistry First International Reference Materials[J]. Clin Chem, 1998,44 (8):1641-649
  • 4Averina M, Nilssen O, Brenn T. Factora behind the increase in cardiovascular mortality in Russia: Apolipoprotein AⅠ and B distribution in the Arkhagelsk study 2000[J]. Clin Chem, 2004, 50(2):346-54
  • 5Bachorik PS, Lovejoy KL, Carroll MD, Johnson CL. Apolipoprotein B and AⅠ distributions in the United States, 1988-1991: results of the National Health and Nutrifion Examinafion Survey Ⅲ(NHANES Ⅲ)[J]. Clin Chem, 1997,43(12):2364-378
  • 6Contois JH, Mcnamara JR, Lammi-Keefe CJ, Wilson PWF, Massov T, Schaefer EJ. Reference intervals for plasma apolipoprotein A1 determined with a sfandardized commerercial immunoturbidimetric assay: result from the Framingham Offspring Study[J]. Clin Chem, 1996,42(4):507-514
  • 7Contois JH, Mcnamara JR, Lmmi-Keefe CJ, Wilson PWF, Massov T, Schaefer EJ. Reference intervals for plasma apolipoprotein B determined with a sfandardized commerercial immunoturbidimetric assay: result from the Framingham Offspring Study[J]. Clin Chem, 1996, 42(4):515-523
  • 8Walldius G, Junger I, Hgolme I. High apolipoprotein B, low apolipoprotein AⅠ, and improvement in the prediction of fatal myocardial infarction(AMORIS Study); a prospective study[J]. Lancet, 2001, 358(12):2025-033
  • 9Moss AJ, Goldstein RE, Marder VJ. Thrombogenic factors and recurrent coronary events[J]. Circulation, 1999,99(19):2517-522
  • 10Lamarche B, Moorjani S, Lupien PJ, Cantin B, Bernard PM, Dagenais GR, et al. Apolipoprotein A1 and B levels and the risk of ischemic heart disease during a five year follow-up of men in the Quebec Cardiovascular study[ J]. Circulation, 1996, 94 (3) : 273-278

共引文献60

同被引文献89

引证文献6

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部